MedPath

Evaluation of near-infrared fluorescence (NIRF) imaging for sentinel lymph node (SLN) detection in squamous cell carcinoma of the vulva: a feasibility study

Conditions
sentinel lymph node
vulvar carcinoma
10038597
10029903
Registration Number
NL-OMON33082
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

female > 21 yrs of age with biopsy proven squamous cell carcinoma of the vulva who are eligible for a sentinel node procedure

Exclusion Criteria

Pregnant women, significant renal (creatinine > 110 ug/l), cardiac, or pulmonary disease (ASA III-IV), History of iodine allergy or anaphylactic reactions to insect bites or medication, presence or history of hyperthyroidism.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>the number and localisation of sentinel lymph node(s) detected with the camera<br /><br>and ICG, compared to the detection with radiocolloid and patent blue</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>n/a</p><br>
© Copyright 2025. All Rights Reserved by MedPath